深圳高新投

Investment focus

A Shenzhen state-owned innovation-finance group whose venture arm acts as "patient capital" — investing early, small, long-term and in hard tech — to back specialized "little giant" and 20+8 industrial-cluster companies through equity plus debt/guarantee financing.